Finding trending penny stocks to buy is not easy. Especially when we consider how much is going on in the stock market as of late, trending penny stocks are not easy to come by. However, with the right research on hand, we can find plenty of good penny stocks that are worth investing in.

When it comes to finding trending penny stocks, one of the best places to start your search is on social media sites like Reddit and Twitter, and news outlets. These sources will often have sections dedicated to discussing penny stocks that are currently trending. Recently, the topic of trending penny stocks has ironically, become trending on these social media platforms. 

[Read More] How To Find The Best Penny Stocks To Buy Using Fundamental Analysis

And as a result, we see the list of penny stocks change on a regular basis. While browsing social media can be great, it is also crucial to consider what is going on in the stock market. Certain events such as press releases, stock market reports, and analyst ratings can all play a role in penny stock prices and whether or not they become trending.

Penny stocks are notoriously volatile, which means that they can rise and fall rapidly in price. For this reason, it’s important to always do your own research before investing in any penny stock. With this in mind, let’s take a look at three penny stocks that are trending right now. 

  1. Yatsen Holding Ltd. (NYSE: YSG)
  2. Dermata Therapeutics Inc. (NASDAQ: DRMA
  3. Trevi Therapeutics Inc. (NASDAQ: TRVI

Yatsen Holding Ltd. (NYSE: YSG) 

On June 30th, shares of YSG stock managed to shoot up by over 7% at midday. And if that’s not enough, in the past five days, shares of YSG stock have shot up by over 40%. This is a major gain for the company and one that has made it highly popularized in the past week or so. For this reason, it’s worth looking into why shares of Yatsen Holding are climbing right now. The most recent news came on June 2nd when it announced that it published an Environmental, Social and Governance (ESG) report. 

[Read More] 3 Penny Stocks To Watch While The Stock Market Is Down

This is a big deal for the company and one that Yatsen saw the benefit of when it came out. If you’re not familiar, Yatsen Holding is a leader in the Chinese beauty market. It offers a variety of cosmetics and skincare brands including Perfect Diary, Little Ondine, Abby’s Choice, Galenic. While YSG stock is highly volatile, the company does have a lot to offer investors. With this in mind, will it be on your penny stocks watchlist?

Penny_Stocks_to_Watch_Yatsen

Dermata Therapeutics Inc. (NASDAQ: DRMA) 

During trading, DRMA stock climbed by over 17%, which is no small feat. And, this is even more impressive given its six month drop of over 60%. The most recent news from the company came on June 13th when it announced that it enrolled its final patient in a Phase 2 Trial of DMT310 for the treatment of moderate to severe rosacea. 

“Completing enrollment of the Phase 2 DMT310 rosacea study is a big step for us as we continue to develop DMT310 as an innovative treatment option for multiple inflammatory skin diseases. We believe that the similarities between rosacea and acne may lead to a similar reduction of inflammatory lesions in rosacea as we saw in our DMT310 Phase 2 acne trial.”

The CEO and President of Dermata, Gerry Proehl

Recently, we’ve seen a major uptick in the bullish sentiment for biotech penny stocks. And as a result, DRMA stock has been climbing recently. As a biotech company, Dermata’s movement is dependent on what news it puts out. With this considered, does DRMA stock deserve a spot on your list of penny stocks to watch.

Penny_Stocks_to_Watch_Dermata

Trevi Therapeutics Inc. (NASDAQ: TRVI) 

Another gainer on June 30th is TRVI stock, which shot up by over 6.5%. And in the past five day period, TRVI stock has climbed by more than 15%. If all that isn’t enough, TRVI stock has shot up by over 230%, which is quite substantial. The most recent news from Trevi came on June 29th when it announced positive results from its Phase 2B/3 PRISM trial of Haduvio in those with prurigo nodularis.

In the study, the company states that 25% of those evaluated at Week 14, met primary endpoints compared to 14% of placebo. This means that the drug could have potential in treating this illness, and that it could see a response from the FDA. Early on this year, the company also stated that it found encouraging interim data from its Phase 2 CANAL trial of Haduvio in idiopathic pulmonary fibrosis patients with chronic cough. As a result of this encouraging news, do you think TRVI stock is worth buying right now or not?

Penny_Stocks_to_Watch_Trevi

Which Penny Stocks Are You Watching Right Now?

Finding the best penny stocks to buy can be tricky. But, with so many different penny stocks to choose from, investors need to have a full understanding of which are worth buying.

[Read More] What to Know About Buying Penny Stocks on June 30th 

Because of this, it all comes down to research and understanding exactly what is going on in the stock market. Right now, the major factors at play include inflation and geopolitical tensions. So, with all of these in mind, which penny stocks are you watching right now?

[reblex id='29520']

Sign up for our FREE Newsletter and get:

  • The Beginner’s Handbook For Trading Penny Stocks
  • Penny Stock Alerts And Ideas
  • Learn To Trade Penny Stocks
  • Free Access to The Fastest Growing Highest Rated Trading Chatroom
Privacy Policy

Midam Ventures, LLC | (305) 306-3854 | 1501 Venera Ave, Coral Gables, FL 33146 | news@pennystocks.com

Leave a Reply

Your email address will not be published.

You May Also Like

3 Biotech Penny Stocks To Watch That Analysts Are Bullish On Today

These biotech penny stocks and former stocks under $5 are turning heads in the analyst community right now